Gene · 4624
Papers4,586
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 4,586
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNA-214-3p Ameliorates LPS-Induced Cardiomyocyte Injury by Inhibiting Cathepsin B. | Folia Biol (Praha) | 2022 | 36384265 | PubTator, text mining | PubMed |
| Dominantly inherited myosin IIa myopathy caused by aberrant splicing of MYH2. | BMC Neurol | 2022 | 36380287 | PubTator, text mining | PubMed |
| Prevalence and characteristics of immune checkpoint inhibitor-related myocardial damage: A prospective observational study. | PLoS One | 2022 | 36378654 | PubTator, text mining | PubMed |
| Training programs in preclinical studies. The example of pulmonary hypertension. Systematic review and meta-analysis. | PLoS One | 2022 | 36378649 | PubTator, text mining | PubMed |
| Effects of Combined Inorganic Nitrate and Nitrite Supplementation on Cardiorespiratory Fitness and Skeletal Muscle Oxidative Capacity in Type 2 Diabetes: A Pilot Randomized Controlled Trial. | Nutrients | 2022 | 36364742 | PubTator, text mining | PubMed |
| Loss of the Nuclear Envelope Protein LAP1B Disrupts the Myogenic Differentiation of Patient-Derived Fibroblasts. | Int J Mol Sci | 2022 | 36362402 | PubTator, text mining | PubMed |
| MicroRNA-381 Regulates Proliferation and Differentiation of Caprine Skeletal Muscle Satellite Cells by Targeting PTEN and JAG2. | Int J Mol Sci | 2022 | 36362373 | PubTator, text mining | PubMed |
| Decellularized Extracellular Matrix Scaffolds for Cardiovascular Tissue Engineering: Current Techniques and Challenges. | Int J Mol Sci | 2022 | 36361824 | PubTator, text mining | PubMed |
| Protective Effects of the Chalcone-Based Derivative AN07 on Inflammation-Associated Myotube Atrophy Induced by Lipopolysaccharide. | Int J Mol Sci | 2022 | 36361718 | PubTator, text mining | PubMed |
Transcriptomic Profiling of Rectus Abdominis Muscle in Women with Gestational Diabetes-Induced Myopathy: Characterization of Pathophysiology and Potential Muscle Biomarkers of Pregnancy-Specific Urinary Incontinence. | Int J Mol Sci | 2022 | 36361671 | PubTator, text mining | PubMed |
| Role of lncRNA Has2os in Skeletal Muscle Differentiation and Regeneration. | Cells | 2022 | 36359891 | PubTator, text mining | PubMed |
| Autologous iPSC-Derived Human Neuromuscular Junction to Model the Pathophysiology of Hereditary Spastic Paraplegia. | Cells | 2022 | 36359747 | PubTator, text mining | PubMed |
| HRas and Myc synergistically induce cell cycle progression and apoptosis of murine cardiomyocytes. | Front Cardiovasc Med | 2022 | 36337898 | PubTator, text mining | PubMed |
| Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in mice. | Clin Sci (Lond) | 2022 | 36331065 | PubTator, text mining | PubMed |
| Celecoxib impairs primary human myoblast proliferation and differentiation independent of cyclooxygenase 2 inhibition. | Physiol Rep | 2022 | 36325583 | PubTator, text mining | PubMed |
| Pathogenesis of Cardiomyopathy Caused by Variants in ALPK3, an Essential Pseudokinase in the Cardiomyocyte Nucleus and Sarcomere. | Circulation | 2022 | 36321451 | PubTator, text mining | PubMed |
| Landscape of RNA-binding proteins in diagnostic utility, immune cell infiltration and PANoptosis features of heart failure. | Front Genet | 2022 | 36313471 | PubTator, text mining | PubMed |
| Whole exome sequencing in Brugada and long QT syndromes revealed novel rare and potential pathogenic mutations related to the dysfunction of the cardiac sodium channel. | Orphanet J Rare Dis | 2022 | 36303204 | PubTator, text mining | PubMed |
| Dysregulated Genes, MicroRNAs, Biological Pathways, and Gastrocnemius Muscle Fiber Types Associated With Progression of Peripheral Artery Disease: A Preliminary Analysis. | J Am Heart Assoc | 2022 | 36300658 | PubTator, text mining | PubMed |
| Unpredicted Aberrant Splicing Products Identified in Postmortem Sudden Cardiac Death Samples. | Int J Mol Sci | 2022 | 36293497 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4624/papers?page=39